Q5106 HCPCS Level II code: Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units

Q5106 is the HCPCS code for “Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units” in CMS’s October 2026 release, in effect from Oct 1, 2026.

Official description

Q5106

Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units

Short description: Inj retacrit non-esrd use

HCPCS · United States

Medicare details

The indicators CMS publishes with Q5106 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Special coverage instructions apply
Medicare pricing
Drugs
ASC
Approved for ambulatory surgical centers
Type of service
Other medical items or services
BETOS category
Other drugs
Added
Jul 1, 2018

Where Q5106 sits

  1. 1Q codesTemporary codes
  2. 2Active code Q5106Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does HCPCS code Q5106 mean?

Q5106 is the HCPCS code for “Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units” in CMS’s HCPCS Level II October 2026 release.

Does Medicare cover Q5106?

CMS lists Q5106’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.